FDA Adverse Event Injury Summary report: N

SOLITAIRE REVASCULARIZATION DEVICE

MDR report key: 4912362 · Received July 14, 2015

Report

Report Number
2029214-2015-00787
Event Type
Injury
Date Received
July 14, 2015
Date of Event
May 4, 2015
Report Date
June 17, 2015
Manufacturer
COVIDIEN (IRVINE)
Product Code
NRY
PMA / PMN Number
K113455
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR EVALUATION AS IT WAS DISCARDED AT THE SITE. BASED ON THE REPORTED INFORMATION, THERE DID NOT APPEAR TO HAVE BEEN ANY DEFECT OF THE DEVICE DURING USE. THE EVENT OCCURRED IN THE PATIENT POST PROCEDURE AND ITS CAUSE WAS UNKNOWN. THE LOT HISTORY RECORD REVIEW OF THE REPORTED LOT NUMBERS SHOWED NO DISCREPANCIES THAT MIGHT HAVE CONTRIBUTED TO THE REPORTED EXPERIENCE. (B)(4).

Description of Event or Problem · 1

(B)(6) STUDY /MEDTRONIC (COVIDIEN) RECEIVED REPORT THAT SHORTLY AFTER THE THROMBECTOMY PROCEDURE, CRANIAL COMPUTED TOMOGRAPHY (CT) IMAGE REVEALED CEREBRAL HEMORRHAGE. HEPARIN REVERSAL AND ANTIHYPERTENSIVE TREATMENTS WERE PROVIDED TO CONTROL THE HEMORRHAGE. OCCLUDED VESSEL WAS LEFT MIDDLE CEREBRAL ARTERY, INITIAL THROMBOLYSIS IN CEREBRAL INFARCTION (TICI) WAS 0. THE TARGET VESSEL WAS NOT RE-VASCULARIZED BY TISSUE PLASMINOGEN ACTIVATOR (TPA) TREATMENT AND SOLITAIRE FR 4-20 MECHANICAL THROMBOLYSIS WAS PERFORMED AND ACHIEVED TICI 3/ ARTERIAL OCCLUSIVE LESION (AOL) 3 WAS ACHIEVED. NINE DAYS LATER, MODIFIED RANKIN SCALE(MRS) WAS 4. ALMOST ONE MONTH LATER, THE PATIENT'S CONDITION WAS CONFIRMED AS BEING STABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
454923 SOLITAIRE REVASCULARIZATION DEVICE CATHETER, THROMBUS RETRIEVER NRY COVIDIEN (IRVINE) SFR-4-20 A026665

Patients

Seq Age Sex Outcome Treatment
1 89 YR Other| R